Insider · CIK 0001791159

Nau Jeffrey

Reports to the SEC for 1 company · PRINCETON, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001791159

Forms 4 and 5

Insider transactions

30 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-01-03	Oyster Point Pharma, Inc.U Disposition from Tender	Director, President and CEO	UDisposition from Tender	−101K sh	—	—	47,975
2023-01-03	Oyster Point Pharma, Inc.D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−48K sh	—	—	0
2023-01-03	Oyster Point Pharma, Inc.D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−1,000 sh	—	—	0
2023-01-03	Oyster Point Pharma, Inc.Performance Stock UnitsD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−350K sh	—	—	0
2023-01-03	Oyster Point Pharma, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−11K sh	—	—	0
2023-01-03	Oyster Point Pharma, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−435K sh	—	—	0
2023-01-03	Oyster Point Pharma, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−387K sh	—	—	0
2023-01-03	Oyster Point Pharma, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−212K sh	—	—	0
2023-01-03	Oyster Point Pharma, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−117K sh	—	—	0
2023-01-03	Oyster Point Pharma, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−210K sh	—	—	0
2022-12-01	Oyster Point Pharma, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−6,217 sh	$11.20	−$69.6K	151,381
2022-12-01	Oyster Point Pharma, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−8,938 sh	$11.20	−$100K	148,660
2022-07-06	Oyster Point Pharma, Inc.Performance Stock UnitsA Award	Director, President and CEO	AAward	+350K sh	—	—	350,000
2022-01-29	Oyster Point Pharma, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−2,607 sh	$11.70	−$30.5K	148,713
2022-01-09	Oyster Point Pharma, Inc.A Award	Director, President and CEO	AAward	+46.7K sh	—	—	157,598
2022-01-09	Oyster Point Pharma, Inc.Employee Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+210K sh	—	—	210,000
2021-10-21	Oyster Point Pharma, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+50K sh	$1.02	+$51K	110,898
2021-10-21	Oyster Point Pharma, Inc.Employee Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−50K sh	—	—	434,774
2021-09-01	Oyster Point Pharma, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+10K sh	$1.02	+$10.2K	60,898
2021-09-01	Oyster Point Pharma, Inc.Employee Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−10K sh	—	—	484,774
2021-04-02	Oyster Point Pharma, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+10K sh	$1.02	+$10.2K	50,898
2021-04-02	Oyster Point Pharma, Inc.Employee Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−10K sh	—	—	494,774
2021-02-19	Oyster Point Pharma, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+10K sh	$1.02	+$10.2K	40,898
2021-02-19	Oyster Point Pharma, Inc.Employee Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−10K sh	—	—	504,774
2021-01-29	Oyster Point Pharma, Inc.A Award	Director, President and CEO	AAward	+25.9K sh	—	—	30,898
2021-01-29	Oyster Point Pharma, Inc.Employee Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+117K sh	—	—	116,539
2020-07-28	Oyster Point Pharma, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+5,000 sh	$1.02	+$5,100	5,000
2020-07-28	Oyster Point Pharma, Inc.Employee Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−5,000 sh	—	—	514,774
2020-02-03	Oyster Point Pharma, Inc.Employee Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+212K sh	—	—	211,533
2019-11-04	Oyster Point Pharma, Inc.P Purchase	Director, President and CEO	PPurchase	+1,000 sh	$16.00	+$16K	1,000

Recent filings

Accepted (ET)
Jan 44
Nau Jeffrey0001209191-23-001084
SEC(opens sec.gov)
Dec 64/A
Nau Jeffrey0001209191-22-060117
SEC(opens sec.gov)
Dec 54
Nau Jeffrey0001209191-22-059794
SEC(opens sec.gov)
Jul 84
Nau Jeffrey0001209191-22-041675
SEC(opens sec.gov)
Jan 114
Nau Jeffrey0001209191-22-002979
SEC(opens sec.gov)
Oct 224
Nau Jeffrey0001209191-21-061371
SEC(opens sec.gov)
Sep 14
Nau Jeffrey0001209191-21-054298
SEC(opens sec.gov)

Companies

Oyster Point Pharma, Inc.Director, President and CEO

Address

C/O OYSTER POINT PHARMA, INC. 202 CARNEGIE CENTER, SUITE 109

PRINCETON, NJ, 08540